Juvenile Diabetes Research Foundation President and CEO Dr. Alan Lewis discusses the organization's priorities, one year in.
Research
The latest research in type 1 diabetes, type 2 diabetes, prediabetes, and beyond. Here you’ll find information on experimental therapies, new data and results, and scientific findings.
26 readers recommended
17 readers recommended
While the benefits of exercise are well known, a recent study presented at the annual Scientific Sessions of the American Heart Association in November provided some...
16 readers recommended
As health care spending becomes an increasing concern, the cost associated with chronic disease – particularly diabetes – is becoming an important issue to consider. A...
33 readers recommended
What will it take to get an artificial pancreas approved? It seems that the path ahead may now be a bit clearer…
15 readers recommended
Beta cell regeneration, dedifferentiation, redifferentiation, isolation, and encapsulation: this article reviews some of the leading curative research, profiling...
16 readers recommended
In April 2006, Dr. Louis Monnier and colleagues published an article in JAMA that challenged the conventional wisdom about diabetes management and complications.
18 readers recommended
In mid-April, the popular press was full of reports on an exciting new paper published in the Journal of the American Medical Society on a stem-cell treatment for type 1...
14 readers recommended
The Journal of the American Medical Association (JAMA) published a controversial meta-analysis suggesting that people who are overweight (a body mass index [BMI] of 25-...
16 readers recommended
Weight expert Dr. David Cummings discusses why bariatric surgery goes far beyond weight loss for type 2 diabetes.
24 readers recommended
The artificial pancreas is coming – will it be connected to an iPhone? What we learned at Children with Diabetes - Focus on Technology.
60 readers recommended
A study in the Journal of the American Medical Association ( JAMA ) found that patients with type 2 diabetes who had been taking the GLP-1 agonists Bydureon (exenatide...
25 readers recommended
On November 18, the University of Virginia (UVA) announced that it received a $3.4 million NIH grant for three artificial pancreas studies to be conducted at UVA and...
22 readers recommended
Where are we on the road to curing type 1 diabetes? Read about our eBook with the American Diabetes Association, with great inspiration from JDRF and the Helmsley...
29 readers recommended
On September 12, Sanofi announced that it withdrew the FDA application for its once-daily GLP-1 agonist lixisenatide (named Lyxumia in Europe) for type 2 diabetes. It is...
25 readers recommended
Dr. Damiano reveals the much anticipated data from the bionic pancreas trials at the biggest diabetes tech conference of the year.
33 readers recommended
Five key insights from April’s big-deal artificial pancreas meeting in Washington, DC.
JDRF and PureTech Launch Groundbreaking New Fund, T1D Innovations, Designed to Fund Type 1 Therapies
20 readers recommended
On Tuesday October 15, JDRF and PureTech announced the launch of T1D Innovations, an exciting new fund that aims to supply crucial funding for the development of type 1...
37 readers recommended
How you can help to prevent type 1 diabetes…
19 readers recommended
The evolving field of type 1 diabetes and how research should improve to get closer to finding a cure.
41 readers recommended
Can more type 2 therapies be used for type 1 diabetes?